May 8th, 2007
IGI Receives National Cancer Institute Grant
More real medical news…
From the press release:
IGI, INC. announced that it has received, a Small Business Technology Transfer (STTR) grant from the National Cancer Institute to evaluate the safety and therapeutic potential of parathyroid hormone PTH (7-34) analog to treat alopecia induced by chemotherapy in breast cancer patients.
In previous animal testing, IGI “successfully formulated PTH […]
.gif)
Recent Comments